PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,250,667 | effect medicin copay voucher vari baselin medic pocket expens insight artemi background persist py inhibitor myocardi infarct mi remain low pocket cost cite factor affect medic complianc examin whether copay intervent affect year persist py inhibitor clinic outcom method result analysi artemi afford real world antiplatelet treatment effect myocardi infarct studi patient mi discharg py inhibitor stratifi baselin pocket medic burden low per month intermedi per month high per month impact voucher intervent year py inhibitor persist examin use logist regress model general estim equat assess rate major advers cardiovascular event among group use kaplan meier estim among mi treat patient hospit patient low copay group middl copay group high copay group patient higher copay group like histori prior mi heart failur diabet compar low copay group p voucher use associ signific higher likelihood year py inhibitor persist regardless copay tier low copay versus without voucher adjust odd ratio ci middl copay adjust ci high copay group adjust ci p interact patient high copay group without voucher similar risk year major advers cardiovascular event compar patient high copay group voucher adjust hazard ratio ci conclus medic copay voucher associ higher medic persist year follow mi regardless pocket medic burden registr url https wwwclinicaltrialsgov uniqu identifi nct | D009203;D058921 | T121;T047 |
36,250,666 | effect run period estim treatment effect cardiovascular random clinic trial meta analyt review background run period may increas adher intervent reduc loss follow whether use run period affect magnitud treatment effect unknown method result conduct meta analysi compar treatment effect systemat review cardiovascular prevent trial use run period match trial use run period match run non run trial popul intervent control outcom calcul ratio relat risk rrrs use random effect meta analysi primari outcom composit cardiovascular event primari analysi match comparison clinic trial use run period versus without run period identifi run trial non run trial n meta analysi statist signific differ magnitud treatment effect run trial relat risk rr ci compar non run trial rr ci rrr ci signific differ rrr secondari outcom caus mortal rrr ci medic discontinu advers event rrr ci post hoc exploratori univari meta regress show averag run period associ statist signific differ treatment effect rrr ci cardiovascular composit outcom statist signific multivari meta regress analysi rrr ci conclus use run period associ differ magnitud treatment effect among cardiovascular prevent trial | D002318 | T047 |
36,250,665 | left atrial function arrhythmia relat small vessel diseas brain mri multi ethnic studi atherosclerosi background atrial fibril af associ increas stroke risk acceler cognit declin associ earli manifest left atrial la impair subclin chang brain structur unclear investig whether abnorm la structur function greater supraventricular ectopi intermitt af associ small vessel diseas magnet reson imag brain method result multi ethnic studi atherosclerosi particip complet day ambulatori electrocardiograph monitor speckl track echocardiographi median month later magnet reson imag brain assess associ la volum index reservoir strain supraventricular ectopi preval af brain magnet reson imag measur small vessel diseas atrophi mean age particip year women multivari model la enlarg associ lower white matter fraction anisotropi greater preval microble reduc la strain indic wors la function associ microble prematur atrial contract associ lower total gray matter volum compar af intermitt af preval af af electrocardiograph monitor associ lower white matter fraction anisotropi sds ci greater preval microble preval ratio ci conclus individu without histori stroke transient ischem attack alter la structur function includ enlarg reduc strain frequent prematur atrial contract intermitt af associ increas marker small vessel diseas detail assess la structur function extend ecg monitor may enabl earli identif individu greater risk small vessel diseas | D018880;D001281;D020521;D050197 | T047;T046 |
36,250,664 | cost ill analysi long term health care resourc use diseas burden patient pulmonari embol insight prefer vte registri background mortal pulmonari embol pe decreas person societ cost among survivor receiv increas attent detail burden would support effici public health resourc alloc aim provid estim econom diseas burden pe also account long term health care use direct indirect cost beyond acut phase method result cost ill analysi bottom approach base data prefer vte registri prevent thromboembol event european registri venous thromboembol calcul direct clinic event anticoagul indirect cost loss product acut pe event month follow euro estim disabl weight month post pe status correspond disabl adjust life year presum owe pe diseas specif cost first year follow incid pe case rang euro euro proport indirect cost total cost cost lowest patient ongo cancer main product loss less evid alreadi burden popul calcul disabl weight survivor cancer free month post pe estim disabl adjust life year per incid case conclus econom burden impos pe societi affect patient consider product loss main driver diseas burden pe remark translat loss rough year healthi life per incid pe case | D054556;D011655 | T047;T046 |
36,250,662 | interleukin trap rilonacept improv health relat qualiti life sleep patient recurr pericard result phase clinic trial rhapsodi background recurr pericard character pain flare inflamm negat impact health relat qualiti life rhapsodi rilonacept inhibit interleukin alpha beta recurr pericard pivot symptomatolog outcom studi evalu efficaci safeti rilonacept il cytokin trap recurr pericard secondari analysi data evalu patient report outcom questionnair score chang trial method result particip complet patient report outcom pro questionnair assess pericard pain health relat qualiti life general health status sleep impact overal symptom sever pro score chang treatment run period week blind random withdraw period week evalu use descript statist mix model repeat measur analys particip pro data run period n random withdraw period n rilonacept placebo includ analys run baselin pro score indic pericard symptom pericard recurr impact health relat qualiti life pro score signific improv p rilonacept treatment run period random withdraw period pro score maintain particip receiv rilonacept receiv placebo experienc recurr pro score deterior time recurr improv follow rilonacept bailout random withdraw week end studi score particip receiv bailout rilonacept similar particip continu rilonacept conclus result demonstr burden pericard recurr improv physic emot health patient recurr pericard rilonacept treatment find extend prior rilonacept efficaci result demonstr improv patient report health relat qualiti life sleep pain global symptom sever treatment registr url https wwwclinicaltrialsgov uniqu identifi nct | D053582;D010493 | T129;T047;T121;T116 |
36,250,659 | diverg converg sex specif time trend ischem stroke year analysi state wide registri germani background incid ischem stroke previous expect rise among countri age popul late sever studi develop countri report declin certain cohort whether appli sex howev uncertain limit data tempor develop incid treatment recoveri method result analyz prospect stroke inpati qualiti assur registri feder state hess germani recruit patient final diagnosi ischem stroke hospit discharg intern classif diseas tenth revis icd mandatori law incid rate calcul base census data inhabit stratifi accord age patient includ male patient femal patient overal incid ischem stroke per per odd ratio ci p male patient incid increas continu per per femal patient decreas per per adjust age ischem stroke male femal patient ci p ci p develop pronounc male patient age year increas per per age group male patient show increas rate prior stroke atrial fibril surpass preval femal patient time multivari regress analysi male patient lower modifi rankin scale discharg compar femal patient differ decreas sinc common ci common ci coincid rise rate endovascular treatment conclus past decad feder state hess overal incid ischem stroke declin predomin femal popul contrast male patient incid risen steeper increas male patient age year might relat increas rate recurr stroke atrial fibril cohort find provid cautionari tale effect secondari prevent femal patient general less like achiev favor outcom sinc introduct endovascular treatment outcom gap decreas | D001281;D000083242;D020521;D002545 | T047;T046 |
36,250,658 | effect endocrin therapi cardiovascular diseas type diabet among breast cancer survivor nation health insur servic databas korea background although endocrin therapi effect treatment breast cancer antiestrogen effect associ increas risk cardiovascular diseas type diabet studi aim investig associ endocrin therapi risk cardiovascular diseas type diabet among breast cancer survivor korea consider various age group method result nation health insur servic databas korea total patient breast cancer age year includ current studi endocrin therapi treat time vari exposur patient categor nonus select estrogen receptor modul user aromatas inhibitor user user time depend cox regress model use estim hazard ratio hrs cis age diagnosi socioeconom status histolog type treatment comorbid adjust model compar nonus select estrogen receptor modul user associ higher risk stroke hr ci venous thromboembol hr ci wherea aromatas inhibitor user associ higher risk coronari heart diseas hr ci risk type diabet associ select estrogen receptor modul user hr ci aromatas inhibitor user hr ci user hr ci particular risk composit cardiovascular diseas higher younger premenopaus patient conclus breast cancer survivor korea endocrin therapi associ higher risk cardiovascular diseas type diabet monitor cancer comorbid endocrin therapi need younger older patient | D001943;D000073116;D002318;D003924 | T201;T047;T191;T101 |
36,250,657 | effect social environ cardiovascular diseas unit state background studi aim examin effect time variant perceiv neighborhood social cohes perceiv neighborhood physic disord local crime cardiovascular diseas cvd incid method result obtain data health retir studi respond age year record histori cvd n includ follow year cox proport hazard model estim cvd incid outcom variabl time variant social environ factor perceiv neighborhood social cohes perceiv neighborhood physic disord local crime exposur control sociodemograph factor cvd relat riskprotect factor result show perceiv neighborhood social cohes associ cvd among black respond hispan white respond perceiv neighborhood physic disord local crime rate associ cvd incid across racial ethnic group conclus result demonstr percept favor social environ need consid reduc cvd risk among black adult research need identifi differ pathway live favor social environ benefit cardiovascular health racial ethnic group | D002318;D064890 | T033;T047;T067 |
36,250,656 | associ hypertriglyceridemia onset age cardiovascular diseas caus mortal adult cohort studi background limit studi involv new onset hypertriglyceridemia studi evalu associ hypertriglyceridemia onset age cardiovascular diseas cvd caus mortal method result popul base prospect studi enrol particip free hypertriglyceridemia cvd baselin kailuan studi initi june particip underw health checkup biennial decemb total particip develop new hypertriglyceridemia age year sex match analysi appli select control subject year new onset case case control pair includ total follow time person year median follow time year primari outcom cvd caus mortal hazard ratio estim adjust baselin characterist total incid cvd event caus mortal event document multivari adjust particip hypertriglyceridemia onset age year highest risk compar match control hazard ratio ci cvd ci caus mortal ci myocardi infarct ci stroke risk estim gradual decreas decad increas onset age hypertriglyceridemia conclus among chines adult hypertriglyceridemia identifi earlier onset age associ higher risk cvd caus mortal | D002318;D015228 | T047 |
36,250,654 | prior sar cov infect associ coronari vasomotor dysfunct assess coronari flow reserv cardiac positron emiss tomographi background cardiovascular complic covid contribut high morbid mortal effect covid infect coronari vasculatur known object studi investig preval coronari vasomotor dysfunct identifi coronari flow reserv cardiac positron emiss tomographi patient previous covid infect method result patient polymeras chain reaction confirm sar cov infect refer myocardi stress perfus positron emiss tomographi imag brigham women hospit april juli compar match control group without prior sar cov infect imag period main outcom preval coronari vasomotor dysfunct myocardi perfus myocardi blood flow reserv quantifi use n ammonia positron emiss tomographi imag thirti four patient prior covid identifi compar match control median time polymeras chain reaction confirm sar cov cardiac positron emiss tomographi month interquartil rang month patient previous hospit covid infect baselin cardiac risk factor common patient covid group abnorm myocardi perfus myocardi blood flow reserv abnorm patient covid compar match control p mean myocardi blood flow reserv lower patient covid compar control patient versus p conclus myocardi blood flow reserv impair patient prior covid infect compar cardiovascular risk factor match control suggest relationship sar cov infect coronari vascular health data highlight need assess long term consequ covid vascular health futur prospect studi | D055414;D000086382;D009202;D003324;D053805 | T060;T201;T047;T067 |
36,250,653 | platelet neutrophil interact thromboinflamm diabet consider novel therapeut approach thromboinflamm becom topic key interest cardiovascular diseas prevent diabet complic interplay thrombosi inflamm diabet specif signific risk vascular thrombot diseas diabet highlight need new better therapeut target help manag prevent vascular thrombo occlus diseas condit similar promin role inflamm diabet spark interest anti inflammatori agent better prevent control vascular diseas investig effect anticoagul antiplatelet intervent patient diabet cardiovascular diseas show potenti role agent decreas morbid mortal neutrophil platelet key player inflamm wound heal respons respect interact neutrophil platelet thought import driver thromboinflamm therefor review describ mechan involv platelet neutrophil interact contribut develop exacerb thromboinflamm context diabet associ comorbid effect observ antithromboticantidiabet treatment physic activitydietari intervent attenu thromboinflamm discuss data suggest mechan involv platelet neutrophil interact platelet activationaggreg recruit neutrophil promis potenti becom therapeut target decreas thromboinflamm patient diabet | D013927;D002318;D003920 | T047;T046 |
36,250,652 | sustain assess wast cook oil base biodiesel plant develop economi base f dematel f ism approach develop clean renew energi resourc long term usag crucial concern develop countri regard biodiesel technolog draw lot public interest throughout world issu associ sustain biodiesel plant intim connect restrict natur resourc polit influenc energi independ econom prosper global stabil therefor paper aspir identifi influenti factor affect sustain biodiesel plant describ interact among studi focus identifi factor base extens literatur review questionnair expert opinion websit context develop economi factor includ social environment econom aspect framework base fuzzi interpret structur model f ism fuzzi decis make trial evalu laboratori f dematel appli investig identifi factor f ism approach allow better understand contextu interact factor classifi base drive depend power fuzzi dematel techniqu facilit identifi influenti influenc factor categor caus effect group find studi suggest legal regulatori complianc polit constraint intern relat health educ public safeti secur five influenti factor need address sustain biodiesel plant paper also present strategi appli guid step decis maker formul polici effect implement sustain growth biodiesel plant | D056804;D031658 | T168;T002;T109 |
36,250,651 | improv fmea method proactiv health care risk assess effect effici covid remot patient telemonitor covid pandem expos need effect har leverag digit tool technolog remot patient monitor rpm rpm gain great popular given need provid effect safe effici remot patient care rpm base noninvas digit technolog aim improv safeti effici health care deliveri report rpm program covid patient follow remot evalu effect treat monitor patient home set analyz inher risk use mix method includ failur mode effect analysi prospect team base risk manag methodolog structur identifi high risk process system failur occur telemonitor remot patient rpm save live improv decis make pandem help prevent health system collaps failur mode effect analysi base assess offer import insight consider evalu futur rpm implement direct rpm solut technic feasibl staff friend achiev high adher rate rigor ongo evalu devic platform essenti clarifi valu guid nation health insur health coverag decis adopt program | D000086382 | T047;T067 |
36,250,647 | latent classif parent involv diabet manag youth type diabet random clinic trial understand parent child relationship influenc diabet manag youth type diabet critic minim risk short long term complic examin class diabet specif parent behavior associ diseas manag well youth type diabet | D003922 | T047 |
36,250,642 | aryl phenanthro imidazol versatil scaffold design optic base sensor fluoresc colorimetr sensor import tool investig chemic composit differ matric includ food environment sampl water high sensit low interfer low detect limit sensor inspir scientist investig class sens molecul ion molecul detect sever exampl fluoresc colorimetr sensor describ literatur review focus particular phenanthro imidazol differ strategi develop obtain phenanthro imidazol enabl modif optic properti upon interact specif analyt sens respons usual involv chang fluoresc intens andor color aris process like photoinduc electron transfer intramolecular charg transfer intramolecular proton transfer excit state frster reson energi transfer review categor sensor two differ group bear formyl group deriv base molecular group differ optic respons phenanthro imidazol base sensor upon interact specif analyt discuss | D007093;D011522 | T121;T196;T109 |
36,250,639 | mycobacterium tuberculosi ku c terminus multi purpos arm bind dna ligd stimul ligat bacteri non homolog end join requir ligas ligd ku ku find break site recruit ligd assist ligd seal phosphodiest backbon bacteri ku contain core domain conserv eukaryot uniqu c terminus divid minim c termin region conserv extend c termin region vari sequenc length speci examin role mycobacterium tuberculosi ku c termin variant remov either extend entir c terminus investig effect ku dna bind rate ku stimul ligat bind affin direct ku ligd interact find extend c terminus limit dna bind identifi key amino acid contribut effect alanin scan mutagenesi minim c terminus suffici stimul ligat doubl strand dna ku core domain also contribut stimul ligat show wildtyp ku ku core domain alon direct bind ligas polymeras domain ligd result suggest ku stimul ligat involv direct interact ku core domain ligd ligas domain addit extend ku c terminus ligd polymeras domain | D009169 | T007 |
36,250,632 | organocatalyt asymmetr synthesi tetrahydroquinolin ortho aminophenyl para quinon methid asymmetr catalyt cycloannul ortho aminophenyl p qms differ type alken construct tetrahydroquinolin contain three contigu stereogen center develop first exampl catalyt asymmetr cycloannul ortho aminophenyl p qms reaction exhibit excel function group toler excel yield exclus diastereoselect high enantioselect obtain effici organocatalyt reaction | D045563;D011804 | T109 |
36,250,627 | residenti proxim oil gas product site hematolog malign case control studi investig associ residenti proxim oil gas product site hematolog malign due cancer cluster german state lower saxoni | D019337;D009369 | T191 |
36,250,623 | revers supramolecular noncoval self assembl determin optic properti format melanin like nanoparticl role noncoval supramolecular self assembl format melanin like np well natur electron transit basi uniqu optic properti strong debat demonstr first stage format synthet melanin polydopamin pda small fraction molecular precursor dopamin da oxid quinon q simpl supramolecular charg transfer ct adduct form thank electron donor electron acceptor properti da q respect adduct also detect hplc ms present broad absorpt band red nir region typic melanin like materi import disaggreg upon dilut easili detect sinc lead disappear ct band indic revers process moreov stabil constant k ct adduct could obtain use simpl associ model | D008543;D053758 | T123;T073;T109 |
36,250,618 | trio base whole exom sequenc patient suspect sporad inborn error immun retrospect cohort studi de novo variant dnvs current routin evalu part diagnost whole exom sequenc wes analysi patient suspect inborn error immun iei | D059472;D056660 | T047;T028 |
36,250,613 | develop fluoresc sensor copper base nanoclust via frster reson energi transfer quench effect vanillin detect two kind copper base metal fluoresc nanoclust success prepar chemic reduct method one cunc synthes direct reduct copper sulfat cuaunc synthes stepwis addit copper salt chloroaur acid cunc use establish fluoresc reson energi transfer fret system neutral red nr due supramolecular effect cyclodextrin cd modifi surfac cunc nr could enter hydrophob caviti cd narrow distanc cunc nr could lead fret fluoresc transfer cunc nr result amplif nr fluoresc signal could use detect vanillin addit cuaunc strong fluoresc use fluoresc probe detect vanillin quench mechan comparison simplic cunc synthesi high select cd made fret method practic may provid new strategi assay vanillin | D003300;D031541 | T123;T196;T121;T059 |
36,250,610 | erythrocyt membran camouflag sirnachemodrug nanoassembl cancer combin therapi combin gene therapi chemotherapi emerg promis strategi multidrug resist mdr cancer treatment howev due signific differ physicochem properti macromolecular oligonucleotid chemodrug co deliveri differ drug combo make great challeng moreov biosafeti carrier poor lysosom escap oligonucleotid main concern combin therapi herein develop facil carrier free strategi co deliv small interf rna sirna posit charg chemodrug term cation amphiphil chemodrug cacd cacd interact negat charg anti p glycoprotein sirna sipgp without extra carrier self assembl sipgpcacd nanoparticl nps sipgpcacd meanwhil cacd also play import role lysosom escap sirna molecular dynam simul experiment character demonstr cacd sirna self assembl nanoparticl furthermor red blood cell membran rbcm use camouflag nps sipgpcacd enhanc physiolog stabil prolong circul time vitro vivo assess reveal excel perform drug resist cancer treatment strategi provid safe effici pathway gene chemo combin therapi mdr cancer | D053758;D009369 | T191;T073 |
36,250,604 | assess clinic valu faecal bile acid profil predict recurr primari clostridioid difficil infect factor influenc recurr risk primari clostridioid difficil infect cdi poor understood tool predict recurr lack perturb bile acid bas contribut cdi pathogenesi may relev primari diseas prognosi | D016360;D003015 | T047;T007;T037 |
36,250,593 | psycholog predictor qualiti life among jordanian cancer patient caregiv caregiv provid care patient cancer often experi emot psycholog stressor burden could influenc sever factor includ cultur context studi examin level emot distress burden effect qualiti life qol jordanian cancer patient caregiv | D017028;D009369 | T099;T098;T191;T097 |
36,250,592 | get deeper molecular event heme bind mechan compar multi level comput studi hasasm hasayp hemophor mani biolog system obtain activ inclus metalloporphyrin one sever bind pocket howev decod molecular mechan compound bind receptor someth wide explor field open question present work appli comput techniqu unravel compar mechan two heme bind system concret hasa hemophor gram negat bacteria serratia marcescen hasasm yersinia pesti hasayp despit high sequenc ident system comparison x ray structur apo holo form suggest differ heme bind mechan hasayp extrem similar structur heme free heme bound form hasasm present larg displac loop ultim lead addit coordin metal respect hasayp combin gaussian acceler molecular dynam simul gamd explicit solvent protein ligand dock optim metalloligand gamd first carri heme free form hemophor protein ligand dock heme perform cluster repres simul best pose subject new seri gamd seri analys reveal follow hasayp conform landscap extrem similar heme bound unbound state limit impact bind cofactor hasasm present slight broader conform landscap apo state visit conform similar x ray holo form heme bound behavior result complex cascad chang interact spread heme bind pocket flexibl loop previous mention studi shed light divers molecular mechan heme bind discuss weight pre organ receptor well induc motion result associ | D001426;D006418 | T123;T116;T109 |
36,250,588 | silyl borylhex enoat chiral reagent asymmetr crotylbor aldehyd nonracem silyl borylhex enoat reagent develop asymmetr crotylbor aldehyd provid z anti homoallyl alcohol possess trisubstitut vinylsilan high yield excel stereo enantioselect divers decor vinylsilan ester group well format function thf ring showcas potenti approach synthesi polyketid natur product | D000447;D012821 | T104;T109 |
36,250,580 | establish sar cov genom surveil within militari health system march decemb report describ sar cov genom surveil conduct depart defens dod global emerg infect surveil branch next generat sequenc bioinformat consortium ngsbc respons covid pandem sampl sequenc data sar cov infect occur among militari health system mhs beneficiari march decemb mhs sampl sequenc countri us state territori geograph combat command repres approxim dod case genom sampl compar public sequenc observ trend similar center diseas control prevent nation surveil us b b sub lineag compris domin variant sar cov sequenc data use monitor transmiss dynam us navi ship militari train center instal new variant emerg dod medic public health practition maxim use genom surveil resourc within dod inform forc health protect measur | D000086382;D000081322;D008889 | T047;T058;T097;T067 |
36,250,577 | biomark point care test guid prescript antibiot peopl acut respiratori infect primari care acut respiratori infect ari far common reason prescrib antibiot primari care even though major ari viral non sever bacteri aetiolog follow mani case antibiot use benefici patient recoveri may expos potenti side effect furthermor limit unnecessari antibiot use key factor control antibiot resist one strategi reduc antibiot use primari care point care biomark point care biomark test inflamm identifi part acut phase respons tissu injuri regardless aetiolog infect trauma inflamm may use surrog marker infect potenti assist physician clinic decis whether use antibiot treat ari biomark may guid antibiot prescript rule serious bacteri infect help identifi patient benefit antibiot treatment anticip updat cochran review first publish | D000900;D012141 | T121;T047;T195 |
36,250,533 | surveil trend sar cov respiratori pathogen among us militari health system beneficiari septemb octob laboratori base respiratori pathogen surveil sar cov respiratori pathogen conduct surveil season among us militari health system mhs beneficiari depart defens global respiratori pathogen surveil program dodgrpsp sentinel particip site submit specimen clinic diagnost test total sar cov posit case identifi associ virus success sequenc two overlap wave sar cov activ observ season b alpha lineag domin februari may juli continu rest season bayx delta lineag predomin septemb compris identifi sar cov lineag emerg sar cov coincid substanti reduct circul season influenza virus non sar cov respiratori pathogen total non sar cov respiratori pathogen identifi includ influenza influenza posit success sequenc major influenza strain sequenc belong influenza hn clade caba common non sarscov respiratori pathogen detect rhinovirusenterovirus n | D000086382;D007251;D000081322;D008889 | T047;T058;T097;T067 |
36,250,520 | clinic effect integr multidisciplinari evid base program prevent intraop pressur injuri high risk children undergo long durat surgic procedur qualiti improv studi prevent hospit acquir pressur injuri hapi children undergo long durat surgic procedur critic import due potenti catastroph sequela general prevent injuri child famili long durat surgic procedur children potenti result high rate hapi due physiolog factor difficulti imposs reposit patient intraop develop implement multi modal multi disciplinari translat hapi prevent qualiti improv program larg european paediatr univers teach hospit intervent compris establish wound prevent team modifi hapi risk assess tool specif educ use prophylact dress fluidiz position long durat surgic procedur part evalu effect program reduc intraop hapi conduct prospect cohort studi children undergo long durat surgic procedur compar outcom match histor cohort children undergon similar surgeri previous year find demonstr reduct hapi intervent cohort p compar compar group control age patholog comorbid surgic durat believ find demonstr possibl signific decreas hapi incid high vulner children use evid base multi modal multidisciplinari hapi prevent strategi | D003668 | T047 |
36,250,519 | regioselect synthesi trifluoromethyl triazol via photocycloaddit sydnon cf cn general regioselect synthesi trifluoromethyl triazol achiev photocycloaddit sydnon trifluoroacetonitril method employ trifluoroacetaldehyd aryl oxim cf cn precursor toler various function group furnish trifluoromethyl triazol product moder good yield mechanist experi reveal energi transfer photocatalyst czipn sydnon substrat | D014230;D013558 | T121;T109 |
36,250,513 | peptid modif interior surfac red blood cell ghost construct catalyt reactor succeed situ synthesi gold nanoparticl au nps interior surfac red blood cell ghost rbcgs cytoskeleton chemic conjug gold bind peptid au np deposit rbcg peptid exhibit enhanc catalyt reactiv reduct nitrophenol due uniform distribut au nps inner surfac coverag au nps surfac peptid | D006046;D053768 | T121;T196;T073 |
36,250,498 | hydrogen sulfid releas polyurethanegelatinkeratin ta conjug mat wound heal hydrogen sulfid h indispens effect wound heal promot anti inflammatori cell prolifer enhanc angiogenesi improv howev small molecular donor drawback burst releas low biocompat studi novel bio macromolecular donor h base keratin thiobenzo acid conjug ktc first synthes thiol disulfid exchang reaction ktc incorpor polyurethan gelatin fabric nanofibr mat electrospin interest ktc donor biocomposit mat capabl releas h trigger glutathion gsh physiolog condit mat excel water absorpt capac demonstr great abil absorb tissu exud addit mat possess notabl antioxid abil therebi protect cell membran oxid cell assay vitro demonstr mat could promot cell prolifer migrat furthermor vivo full thick defect model verifi h releas wound dress mat could acceler granul tissu format enhanc collagen deposit promot angiogenesi base advantag wound dress mat great potenti applic wound heal | D005780;D006862 | T121;T116;T131;T197;T130 |
36,250,497 | brain metabol correl dopaminerg denerv prodrom earli parkinson diseas remain unclear brain metabol activ transform respons dopamin defici prodrom earli phase parkinson diseas pd | D009662;D010300;D020187 | T047;T048;T109 |
36,250,494 | high sensit fluoresc nanoprob amplifi detect formaldehyd non conjug polym nanoparticl pnps wide report analyt applic howev develop effect fluoresc signal amplif scheme base pnps remain challeng studi polyethyleneimin base polym nanoparticl pei pnps synthes interrog fluoresc signal amplif analyt applic pnps pei pnps aggreg pei polym structur abl confin larg densiti sub fluorophor individu nanoparticl enabl realize signal amplif effect herein formaldehyd fa util enhanc fluoresc intens pei pnps model confirm proof concept strategi result show fold signal enhanc abil sens fa observ use pei pnps prepar higher pei concentr possibl mechan fa amplifi sens studi particular fa recognit unit sub fluorophor pei pnps simultan form prepar pei pnps avoid leakag effect dye believ water solubl biocompat pei pnps promis candid detect endogen fa live system | D011094;D053758 | T130;T073;T109 |
36,250,493 | design foldabl respons drug elut polyacryl intraocular len bulk materi prevent postop complic posterior capsular opacif pco result undesir intracapsular cell prolifer common complic intraocular len iol implant cataract surgeri recent year iol develop drug deliveri platform compar tradit eye drop drug load iol characterist independ patient complianc oper except surgic implant work seri poli glycidyl methacryl co ethoxyethoxi ethyl acryl pge acryl intraocular len materi synthes drug deliveri platform pge synthes crosslink agent excel optic foldabl thermomechan properti aldehyd group subsequ introduc pge chain antiprolif drug doxorubicin immobil onto pge chain via h sensit imin bond iol exhibit h depend dox releas behavior simul patholog environ vitro vivo systemat evalu indic respons drug elut pge iol effect prevent pco | D007903;D018918;D002386;D007910 | T061;T190;T033;T023;T074;T047 |
36,250,492 | align prior total knee arthroplasti high tibial osteotomi patient effect subsequ function outcom influenc prior high tibial osteotomi hto total knee arthroplasti tka function outcom remain wide debat align fail hto pose technic challeng subsequ tka primari aim studi evalu influenc hto align clinic outcom subsequ tka secondari aim compar time tka hto align type | D019645;D020370 | T061;T047 |
36,250,491 | suicid behavior among heterosexu lesbiangay bisexu activ compon servic member us arm forc lesbian gay bisexu lgb individu particular high risk suicid behavior general popul unit state studi aim determin differ frequenc lifetim suicid ideat suicid attempt heterosexu lesbiangay bisexu servic member activ compon us arm forc self report data depart defens health relat behavior survey use analysi multivari logist regress demonstr lesbiangay bisexu servic member like report past suicid ideat compar heterosexu servic member adjust odd ratio aor lesbiangay ci aor bisexu ci similar result observ past suicid attempt lesbiangay aor ci bisexu sms aor ci despit dispar suicid ideat attempt sexual orient major servic member behavior health questionnair assess sexual orient clinic screen suicid risk militari set factor sexual orient comprehens assess associ sexual orient suicid behavior popul | D008889;D000072339 | T098;T097 |
36,250,486 | associ isol abnorm coagul profil transfus follow major surgeri nsqip analysi individu without bleed disord preoper coagul screen patient without bleed disord remain controversi combinatori risk inr aptt platelet count plt abnorm lead bleed requir transfus known patient examin associ abnorm coagul profil risk transfus follow common elect surgeri patient without bleed disord | D058996;D001778 | T047;T057 |
36,250,485 | cystein phenylalanin deriv self assembl nanoparticl glutathion respons drug deliveri system yeast despit avail differ antifung drug market overal use remain question due relat high toxic profil exert mani case addit emerg drug resist antifung agent matter concern thus becom imper explor innov drug deliveri vehicl deliv antifung drug enhanc efficaci mitig unwant side effect tackl surg antifung resist consid fact piec work synthes stimulus glutathion respons dipeptid base self assembl nanoparticl nps explor establish redox respons antifung drug deliveri relat hydrophob drug terbinafin terb saccharomyc cerevisia cerevisia nps prepar use relat aqueous environ oppos terb formul administ most non polar solvent limit biocompat nps demonstr encapsul effici around terb result complet inhibit yeast cell growth dose g ml drug load formul thus biocompat aqueous dipeptid base redox respons nps offer promis drug deliveri platform provid enhanc antifung drug deliveri heighten efficaci biocompat | D012441;D053758 | T004;T073 |
36,250,482 | sever methyl bromid poison caus earli acut renal failur anuria case report methyl bromid pre plant soil fumig wide use control nematod insect fungi farmland methyl bromid enter human bodi dermal absorpt inhal damag respiratori nervous circulatori urinari system year old man inhal larg amount methyl bromid admit depart present respiratori failur pink foami sputum start dexamethason alanyl glutamin sulbactam furosemid vitamin b mous nerv growth factor treatment mechan ventil continu venoven hemodiafiltr cvvhf perform daili subsequ develop coagulopathi cvvhf protamin recombin human brain natriuret peptid albumin administ intraven notabl patient develop sustain anuria eventu die owe multipl organ failur specif failur brain heart lung kidney report present diagnosi clinic cours manag prognosi patient treat hospit sever methyl bromid poison | D058186;D001002 | T047;T037 |
36,250,475 | earli diverg translat initi elong factor protein translat foundat attribut live cell translat function carri ribosom critic depend assort protein interact partner collect refer translat machineri various studi suggest diversif translat machineri occur prior last univers common ancestor yet unclear whether predecessor extant translat machineri factor function distinct modern counterpart reconstruct share ancestr trajectori subsequ evolut essenti translat factor gtpase elong factor ef tu aef aeef initi factor aifbeifb base upon similar function structur homolog propos ef tu emerg ancient common ancestor generat phylogenet tree ef tu protein reconstruct ancestr sequenc correspond deepest node share evolutionari histori includ last common ef tu ancestor identifi residu domain substitut well structur chang along phylogenet histori develop evolutionari scenario origin diverg function refin ef tu protein analys suggest common ancestor ef tu like gtpase protein given central import translat machineri cellular life earliest evolutionari constraint trajectori key character univers constraint capabl cellular evolut | D010444;D039881 | T123;T126;T116 |
36,250,474 | reloc new facil challeng cord blood bank transferr brazil cord blood bank facil plan execut transferr entir oper new site south brazil transport ln freezer complex process extens plan essenti minim risk damag product storag unit | D001771;D005312 | T058;T073;T093;T031 |
36,250,467 | impair tigit express b cell drive circul follicular helper cell expans multipl sclerosi b cell deplet patient relaps remit multipl sclerosi rrms mark prevent new mri detect lesion diseas activ suggest hypothesi alter b cell function lead activ cell drive diseas pathogenesi perform comprehens analys cd ligand cdl il stimul memori b cell patient ms healthi age match control model help follicular helper cell tfh cell found differenti gene express signatur multipl b cell pathway strike impair tigit express ms deriv b cell mediat dysregul transcript factor tcf activ circul tfh cell ctfh cell express cd ligand tigit tigit b cell reveal capac suppress prolifer il produc ctfh cell via tigitcd axi final ccr ctfh cell signific increas patient ms frequenc invers correl tigit b cell togeth data suggest dysregul negat feedback loop tigit memori b cell ctfh cell ms drive activ immun system diseas | D001402;D020381;D009103 | T129;T123;T116;T025;T192;T047 |
36,250,466 | cytometr analysi reveal associ allergen respons natur killer cell human peanut allergi food allergi lead caus anaphylaxi allergen specif immun respons innat adapt immun system play key role pathogenesi conduct comprehens phenotyp function investig immun cell respons nonallerg na peanut allerg pa particip cultur media alon peanut protein found surpris nk cell activ strong associ immun respons allergen pa particip peanut respons nk cell manifest distinct express pattern pa particip compar na particip allergen activ nk cell express th immun regulatori cytokin hint potenti function role mediat regul th allerg respons deplet cd cell attenu respons nk cell peanut allergen stimul suggest peanut respons nk cell cell depend also show oral immun therapi associ decreas nk respons peanut allergen stimul vitro result demonstr nk cell associ food allerg immun respons magnitud mobil cell popul suggest play function role allerg immun | D005512;D021183 | T047;T046 |
36,250,465 | szt maintain hematopoiet stem cell homeostasi via nutrient mediat mtorc regul mtorc pathway coordin nutrient growth factor signal maintain organism homeostasi whether nutrient signal mtorc regul stem cell function remain unknown show szt protein requir mtorc downregul upon nutrient depriv critic hematopoiet stem cell hsc homeostasi ablat szt hscs decreas reserv impair repopul capac hscs furthermor ablat szt tsc repressor mtorc nutrient growth factor arm respect led rapid hsc deplet pancytopenia prematur death mice mechanist loss either szt tsc hscs led mild elev mtorc activ reactiv oxygen speci ros product loss szt tsc hand simultan produc dramat synergist effect approxim fold increas mtorc activ approxim fold increas ros product rapid deplet hscs data demonstr critic role nutrient mtorc signal hsc homeostasi uncov strong synergist effect nutrient growth factor mediat mtorc regul stem cell | D006412;D000078622 | T168;T025 |
36,250,464 | curious case tryptophan pregnanc patient caregiv fulli inform live organ donat prior kidney injuri affect futur health need better understand role kidney reserv physiolog adapt especi pregnanc import epidemiolog studi reason live kidney donor increas risk develop preeclampsia hypertens disord pregnanc serious implic matern fetal health despit import find mechanist basi increas risk understood issu jci dupont berg co author provid strong evid impair placent perfus placent ischemia increas solubl fms like tyrosin kinas sflt matern preeclampsia like phenotyp associ inabl upregul l tryptophan deriv l kynurenin pathway pregnanc mice blunt renal reserv surpris revel underscor curious quidditi l tryptophan | D011225;D040281 | T046;T126;T116;T192 |
36,250,462 | il depend extravas preexist lung restrict autoantibodi lung transplant activ complement mediat primari graft dysfunct preexist lung restrict autoantibodi lras associ higher incid primari graft dysfunct pgd although remain unclear whether lras drive pathogenesi syngen murin left lung transplant recipi preexist lras worsen graft dysfunct evid impair gas exchang increas pulmonari edema activ damag associ pathway lung epitheli cell lra mediat injuri distinct ischemia reperfus injuri sinc delet donor nonclass monocyt host neutrophil could prevent graft dysfunct lra pretreat recipi whole lra igg molecul necessari lung injuri mediat classic altern complement pathway revers complement inhibit howev delet fc receptor donor macrophag mannos bind lectin recipi mice fail rescu lung function lra mediat injuri local transplant lung depend il mediat permeabil pulmonari vascular endothelium allow extravas antibodi genet delet pharmacolog inhibit il r donor lung prevent lra induc graft injuri human preexist lras independ risk factor sever pgd could treat plasmapheresi complement blockad conclud preexist lras compound ischemia reperfus injuri worsen pgd complement inhibit may effect | D016040;D055031;D015427 | T061;T046;T037 |
36,250,461 | elev blood glucos appear islet autoantibodi children etiolog type diabet polygen environment determin lead autoimmun respons pancreat cell promot cell death autoimmun consid silent without metabol consequ late preclin stage remain unknown earli diseas process pancreat cell compromis address investig preprandi nonfast postprandi blood glucos concentr islet autoantibodi develop children high genet risk type diabet pre postprandi blood glucos decreas month age gradual increas final measur year age determin blood glucos trajectori first year life includ sex bodi mass index glucos relat genet risk score type diabet suscept in gene children develop islet autoantibodi earli elev blood glucos concentr sharp sustain rise postprandi blood glucos observ around month prior autoantibodi seroconvers increas postprandi subsequ preprandi valu seroconvers find show heterogen blood glucos control infanc earli childhood suggest islet autoimmun concurr subsequ insult pancreat islet | D003922;D007515 | T047;T023 |
36,250,460 | type diabet role autoimmun cell death current dogma type diabet pathogenesi assert autoimmun attack lead destruct pancreat cell subsequ hyperglycemia dogma base islet autoantibodi emerg prior onset type diabet issu jci warnck et al report investig develop hyperglycemia diabet threshold earli proxi cell demis surpris found elev blood glucos preced appear autoimmun observ call question import autoimmun primari caus cell destruct implic prevent treatment diabet | D003922;D006943;D050417;D007515 | T033;T047;T025;T023 |
36,250,459 | revolution cardiovascular medicin target therapi cardiac conduct system arrhythmogen cardiovascular disord associ consider morbid mortal whether cardiac conduct diseas caus genet defect procedur perturb valvular diseas ischemia age heart failur new therapi warrant issu jci goodyer et al use state art technolog imag cardiac conduct system ccs real time deliv target therapi ccs subcompon find advanc abil imag treat specif lineag within adult heart potenti broader applic treatment cardiovascular diseas | D001145;D006329 | T022;T047 |
36,250,455 | editori perspect use lever improv mental health transit year old learn evid across whole health social care beyond reflect find scope review paper adu et al insight commentari emma toni wakefield gave opportun ask us whether user carer practition educ research policymak togeth convert grow evid best model transit realiti one deliv across pathway care across geographi posit sustain measur whole system chang transit age youth tay extant mental health problem also model abl sustain popul mental health well year old commentari discuss essenti framework need develop system chang discuss paper | D008603;D000075485 | T058;T041 |
36,250,453 | editori suicid prevent youth reduc death suicid youth urgent public health goal effect treatment approach remain limit editori review new research publish issu child adolesc mental health may inform youth suicid prevent effort includ open trial new famili focus group intervent youth suicid ideat find show life problem associ present emerg depart self harm vari age gender need multi compon treatment flexibl target rang life problemsrisk factor includ famili treatment discuss along need find way make intervent scalabl final editori address issu debat discuss role mind dialect behavior therapi suicid youth need care monitor examin effect safeti mind patient popul | D016728;D013405 | T033;T055 |
36,250,447 | scan electron microscop studi antenn sensilla aplosonyx chalybaeus hope coleoptera chrysomelida aplosonyx chalybaeus major insect pest plant colocasia common found north eastern region india antenna chalybaeus filiform compos scape pedicel flagellum nine flagellomer type structur distribut sensilla antenna adult chalybaeus coleoptera chrysomelida examin scan electron microscopi eight differ type sensilla observ antenna use scan electron microscopi sensilla trichodea sensilla chaetica sensilla basiconica multipor groov peg sensilla auricillica sensilla styloconica glandular plate bhm sensilla base extern morpholog distribut antenn sensilla observ discuss antenna addit discuss putat function sensilla observ base extern morpholog distribut characterist antenna speci research highlight extern morpholog distribut various antenn sensilla male femal aplosonyx chalybaeus describ eight type subtyp antenn sensilla observ distinct sexual dimorph observ occurr distribut various sensilla | D001517;D009036 | T204 |
36,250,446 | combin cartilag growth calcif pattern wing fin rajida chondrichthy diverg model endochondr ossif tetrapod relationship cartilag growth miner pattern studi adult rajida x ray morphologymorphometri undecalcifi resin embed heat deprotein histolog scan electron microscopi morphometri wing fin nine central ray youngest oldest specimen document signific decrement radial mean length inner middl outer zone without regular progress along ray suggest singl radial length growth regul way align inter radial joint parallel wing metapterygia curvatur tran illumin heat deprotein techniqu show polygon cylindr morphotyp tessera whose align pattern rang mono columnar bi columnar multi columnar crustal like layout histolog tessel cartilag allow identifi zone incom miner deposit character enhanc duplic rate chondrocyt format isogen group whose morpholog topographi suggest relationship impend format radial calcifi column morphotyp layout radial tessera relat mechan demand stiffen sizemass radial cartilag bodi cartilag calcif pattern batoid model share sever morpholog featur tetrapod endochondr ossif chondrocyt high duplic rate align row increas volum chondrocyt lacuna without typic geometri metaphys growth plate research highlight wing fin system consist stiff radial mobil inter radial joint flat inter radial membran adapt mechan demand wing wave movement growth occur form mix calcifi uncalcifi cartilag textur develop intrins tension stress document morphoanatom data | D012860 | T013 |
36,250,445 | caspas like proteas involv ethylen induc program cell death aerenchyma format helianthus annuus stem previous research report hypox condit ethylen treatment great trigger program cell death pcd occurr induc format aerenchyma adapt stress environ helianthus annuus stem caspas like proteas clp regulatori signal also involv process pcd adapt low oxygen environ howev relationship ethylen clp seldom report herein understand regulatori role ethylen clp signal molecul aerenchyma format investig effect exogen ethephon et ethylen percept inhibitor methylcyclopropen mcp treatment mcp et morpholog physiolog characterist aerenchyma format h annuus stem result show lysigen aerenchyma format h annuus stem induc et immunohistochemistri assay indic clp activ rais format stage aerenchyma format decreas expand phase aerenchyma format western blot illustr express clp also increas within h ethylen signal induc aerenchyma format activ clp higher et treat seedl control mcp treat seedl phenomenon also observ caspas activ assay result reveal causal interdepend relationship et clp signal process aerenchyma format regul pcd initi h annuus stem | D006368 | T002 |
36,250,444 | amaranth calcium oxal crystal associ chloroplast structur protein calcium oxal caox crystal plant form crystal idioblast cell specif geometr shape propos function includ calcium homeostasi carbon sourc among other amaranth plant present high toler abiot stress accumul consider amount caox crystal howev studi focus character crystal ultrastructur none relat identifi protein bound inform great interest understand mechan relat caox crystal format support propos function thus work aim character caox crystal amaranth leav crystal purifi protein bound isol identifi nlc msms leaf section analyz light electron microscopi identifi protein relat chloroplast atpb synthas rubisco larg subunit cell wall relat protein valid immunohistochemistri immunogold label addit observ caox crystal idioblast form parenchyma cell associ mesophyl vein thylakoid membran degrad chloroplast turn crystal chamber result signific advanc understand mechan caox crystal format potenti function altern carbon sourc leav | D002118;D002129 | T123;T196;T121;T109 |
36,250,437 | mir p inhibit inflamm target mapk penicillin induc astrocyt epilepsi caus physic mental damag patient well known microrna mirna provid therapeut target potenti patient epilepsi mir p previous report downregul tempor lobe epilepsi tle patient howev detail function epilepsi unknown | D035683;D004827 | T033;T123;T047;T114 |
36,250,436 | relationship conscious level structur neural connect medial prefront cortex hypox ischem brain injuri pilot studi pilot studi investig relationship conscious level structur neural connect medial prefront cortex mpfc snc patient hypox ischem brain injuri hi bi use diffus tensor tractographi dtt twenti three patient hi bi recruit studi base predefin inclus criteria conscious level evalu use glasgow coma scale gcs coma recoveri scale revis crs r use dtt mpfc snc reconstruct patient averag fraction anisotropi fa appar diffus coeffici adc voxel number vn mpfc snc hemispher determin gcs score show moder posit correl fa valu vn mpfc snc fa r vn r p strong negat correl adc valu r p crs r score strong posit negat correl fa adc valu mpfc snc respect fa r adc r p moder posit correl vn mpfc snc r p found sever injuri mpfc snc close relat conscious level result suggest mpfc snc appear neural correl control conscious patient hi bi base result believ mpfc could target area noninvas neurostimul therapi patient impair conscious follow hi bi | D020925;D001930 | T047;T037 |
36,250,434 | impact transcrani altern current stimul work memori select attent athlet attent deficit hyperact disord random control trial current studi aim investig impact transcrani altern current stimul tac work memori select attent athlet attent deficit hyperact disord adhd | D001289;D008570;D065908 | T061;T041;T048 |
36,250,432 | sympathet blockag attenu fast induc hepat steatosi although central nervous system coordin whole bodi metabol neural mechan hepat steatosi remain unclear studi aim explor neural mechan fast induc hepat steatosi mice pretreat hydroxydopamin block sympathet nerv activ fast explor potenti effect chemic sympathectomi fast induc hepat steatosi transcript chang twenti four hour fast led obvious hepat steatosi low core temperatur similar effect cold induc white adipos lipolysi alter hepat mrna express reveal hepat lipid accumul result increas hepat lipogenesi decreas fatti acid oxid enhanc fatti acid uptak indic upregul cd blockag sympathet nervous system via chemic sympathectomi attenu fast induc hepat steatosi suppress cd upregul liver obvious alter express gene associ lipogenesi fatti acid oxid find indic sympathet nervous system orchestr mechan fast induc hepat steatosi via modul cd express adipos fat traffick liver provid clue reveal new target fatti liver diseas | D005215;D005234 | T033;T055;T047 |
36,250,431 | brain respons gate open mechan perceptu conceptu mismatch back match task although work memori perform predict gate mechan part attent control attent control effect domain specif match process back task lack neural evid | D005071;D008570 | T041;T042 |
36,250,430 | transplant olfactori ensheath cell decreas local serolog monocyt chemoattract protein level acut phase rat spinal cord injuri monocyt chemoattract protein mcp one upregul cytokin spinal cord serum throughout acut spinal cord injuri sci olfactori ensheath cell oec transplant improv sci multipl mechan includ immunomodul studi aim investig whether oec amelior acut inflamm sci modul mcp express | D018932;D013119 | T129;T116;T037 |
36,250,427 | comprehens review method studi lncrna protein interact solut long non code rnas lncrnas rrna trna earlier assum junk genom materi howev recent advanc genom method highlight role housekeep also progress diseas like cancer well viral infect lncrnas owe length short rang long rang interact result complex fold structur recruit various biomolecul enabl lncrnas undertak various biolog function use cell lysat pull assay increas number lnrnas interact protein identifi interact exploit develop target novel therapeut strategi inhibit lncrna protein interact review attempt succinct techniqu identifi character lnrnas protein interact ie affin stoichiometri thermodynam furthermor use sophist biophys techniqu one also perform size estim determin low resolut structur sinc method studi biomolecul solut larg scale structur observ perform real time review attempt briefli introduc reader biochem biophys techniqu util method obtain holist character biomolecul interest addit note use method limit character interact molecul also use determin efficaci therapeut molecul disrupt interact | D062085 | T123;T114 |
36,250,421 | kinemat align versus mechan align total knee arthroplasti date meta analysi purpos meta analysi compar efficaci imag paramet kinemat align ka mechan align total knee arthroplasti tka evalu whether patient undergo ka tka benefit undergo tka | D019645;D007720;D020370 | T061;T047;T074 |
36,250,418 | adjunct therapi addit land base exercis therapi osteoarthr hip knee land base exercis therapi recommend clinic guidelin hip knee osteoarthr adjunct non pharmacolog therapi common use alongsid exercis hip knee osteoarthr manag cumul evid adjunct land base exercis therapi lack | D015207;D020370 | T047 |
36,250,404 | pd catalys ag assist c h alkenyl benzophosphol palladium catalys silver assist regioselect c h alkenyl benzophosphol termin alken develop palladium catalysi accommod styren electron defici alken includ ester keton nitril phosphon thus protocol enabl rapid construct various benzophosphol vinylen conjug two simpl c h start substrat optic properti newli synthes c alkenyl benzophosphol also investig | D010165;D000475 | T196;T109 |
36,250,399 | neglect impact patient decis make associ genet test highlight non health relat impact associ genet test gt know one genet status health technolog assess hta analyst hta audienc may appropri consid pros con gt wherea health relat impact gt eg increas healthi behavior avoid harm unnecessari treatment frequent assess hta non health relat impact less often consid difficult measur present challeng accur assess whether genet test fund health system hta understand place emphasi measur clinic outcom risk creat gt cultur pro test without suffici recognit burden gt also risk fund genet test provid littl clinic benefit nonetheless may seen autonomi enhanc recent develop expand hta framework includ ethic analys help address gap evid bring awar non health relat impact gt hta analyst awar impact choos appropri framework assess genet test use method evalu impact new report tool present may assist evalu | D005820;D013673 | T060;T058;T059 |
36,250,398 | low oxygen level high redox heterogen late ediacaran shallow ocean constraint ca mg cece dengi format south china previous studi focus redox state deep water lead incomplet understand spatiotempor evolut redox stratifi ocean ediacaran cambrian transit order decod redox condit shallow marin environ late ediacaran studi present ca mg carbon oxygen isotop major trace rare earth element data subtid peritid dolomit dengi format yangba south china combin report radiometr biostratigraph data dengi format coeval success worldwid subdivid posit c excurs lower part stabl c plateau general middl upper part overal low ca mg ratio molmol slight negat ce anomali cece sn point low oxygen level shallow marin environ yangba moreov four puls negat excurs cece sn associ two posit excurs ca mg ratio molmol observ indic weak oxygen shallow marin environ comparison upper ediacaran shallow water success worldwid reveal cece sn ca mg valu general fall precambrian rang tempor trend differ among success eg ce anomali profil signific differ yangba yangtz gorg section point low oxygen level high redox heterogen surfac ocean consist widespread anoxia reveal low u valu report previous studi thus atmospher oxygen concentr late ediacaran estim low similar case mesoproterozo earli neoproterozo period | D005580;D012623 | T167 |
36,250,393 | ccr express tendon resid macrophag cell ccr defici impair tendon heal via blunt involv tendon resid circul monocytesmacrophag tendon heal macrophag thought key mediat scar tissu format prevent success function restor tendon howev macrophag critic success tendon heal aid wound debrid extracellular matrix deposit promot fibroblast prolifer recent work sought better defin multi facet function macrophag use deplet studi studi identifi tendon resid macrophag popul begin delin function tendon resid versus circul deriv macrophag examin tendon heal phenotyp chemokin receptor ccr report ccr gfp knockout mice ccr chemokin receptor primarili found surfac circul bone marrow deriv monocyt ccr import mediat macrophag recruit wound environ surpris ccr gfp cell present tendon adult homeostasi singl cell rna sequenc identifi cell tendon resid macrophag cell homeostasi heal ccr knockout result substanti decreas ccr gfp cell pan macrophag addit loss ccr result reduc number myofibroblast imped function recoveri late heal studi highlight heterogen tendon resid recruit immun cell contribut follow injuri establish import role ccr modul adult tendon cell environ tendon heal process | D009000;D054390 | T116;T025;T192 |
36,250,384 | dna bind antitubercular antibacteri anticanc studi newli design piano stool ruthenium ii complex chemotherapeut potenti ruthenium ii complex recent attract research interest antibacteri anticanc agent studi two novel half sandwich imin base ru complex ru p cymen cl l pf ru ru p cymen cl l pf ru report deoxyribonucl acid dna bind antitubercular antibacteri anticanc activ molecular structur ru obtain singl crystal x ray crystallographi dna interact studi conduct uv vis absorb fluoresc spectral titrat gave rise dna bind constant k b ru ru respect stern volmer bind constant k sv valu ru ru respect vitro antitubercular activ evalu mycobacterium tuberculosi hra antibacteri potenti ru complex examin gram negat escherichia coli pseudomona aeruginosa gram posit staphylococcus aureus bacillus subtili bacteria half maxim inhibitori concentr ic valu antitubercular activ ru ru respect cytotox studi complex perform human breast cancer cell line mcf human embryon kidney cell line hek normal cell studi reveal meaning activ ru complex cancer mcf cell viabil hek normal cell presenc ru higher compar refer drug fu suggest kind ru complex could potenti applic metallopharmaceut | D012428;D056831;D000970 | T104;T196;T121;T109 |
36,250,383 | variabl calodium hepaticum egg sigmodontin host speci geometr morphometr analysi calodium hepaticum zoonot nematod worldwid distribut although host rang c hepaticum includ wide spectrum mammal includ human parasit predomin associ famili murida cricetida sever sigmodontina speci argentina found infect c hepaticum high preval akodon azara present studi focus c hepaticum egg natur infect three speci sigmodontin rodent argentina egg genet character intergen rrna region object work propos new analyt methodolog ii morpholog character c hepaticum egg three sigmodontina speci azara calomi callidus oligoryzomi flavescen analys made comput imag analysi system base new standard measur geometr morphometr tool result factor map clear illustr global size differ parasit egg three sigmodontina speci analys degre similar egg popul assess pairwis mahalanobi distanc show largest distanc detect parasit egg c callidus flavescen herein phenotyp plastic c hepaticum egg shown signific posit correl obtain egg parasit princip compon rodent corpor characterist weight liver weight rodent length rodent bodi condit use geometr morphometr analysi studi relationship c hepaticum host must highlight high preval observ azara associ wide size rang parasit egg evidenc princip compon analysi suggest azara sigmodontina host speci play import role reservoir host c hepaticum new world | D058507;D012376 | T047;T070 |
36,250,380 | nra modul intestin smooth muscl cell phenotyp dampen inflamm associ intestin remodel strictur format common complic crohn diseas cd driven enhanc deposit extracellular matrix ecm expans intestin smooth muscl layer nuclear receptor subfamili group member nra orphan nuclear receptor exhibit anti prolif effect smooth muscl cell smcs hypothes nra regul intestin smc prolifer muscl thicken context inflamm intestin smcs isol nra nra litterm subject shotgun proteom analysi prolifer bioenerget assay prolifer assess presenc absenc nra agonist cytosporon b csn b mercaptopurin mp vivo compar colon smooth muscl thicken nra nra mice use chronic dextran sulfat sodium dss model coliti second sampyitfc mice model spontan ileiti treat csn b small intestin smooth muscl thicken assess smcs isol nra mice exhibit increas abund protein relat cell prolifer metabol ecm product wherea nra smcs high express protein relat regul actin cytoskeleton contractil process smcs isol nra mice exhibit increas prolifer alter cellular metabol wherea activ nra attenu prolifer vivo nra mice exhibit increas colon smooth muscl thick follow repeat cycl dss activ nra csn b context establish inflamm reduc ileal smooth muscl thicken sampyitfc mice target nra may provid novel approach regul intestin smc phenotyp limit excess prolifer contribut strictur develop cd | D003424;D015122 | T121;T047;T114 |
36,250,349 | applic en bloc urethr mucos flap spare techniqu improv function outcom holmium laser enucl prostat retrospect case control studi purpos studi studi feasibl holmium laser enucl prostat holep en bloc urethr mucos flap spare techniqu treat benign prostat hyperplasia bph patient evalu influenc modifi techniqu urinari function cohort bph patient underw holep june octob among patient underw convent en bloc holep patient underw holep en bloc urethr mucos flap spare techniqu basic characterist volum prostat urodynam data periop paramet record comparison outcom paramet includ intern prostat symptom score ipss maximum urinari flow rate qmax post void residu pvr qualiti life score qol incid de novo stress urinari incontin sui basic characterist equival group holep procedur smooth carri periop complic low show signific differ follow period month longer ipss qmax qol pvr improv postoper group statist differ paramet two group consid postop sui occurr short term long term sui modifi holep group signific less convent holep group p summari holep use en bloc urethr mucos flap spare techniqu safe effect treatment bph patient especi prevent postop sui | D053844;D011470;D014550 | T047;T074;T191;T073 |
36,250,347 | insulin stimul atyp protein kinas c mediat phosphoryl neuron adaptor fe potenti neurit outgrowth activ arf rac signal neurit outgrowth fundament process neuron produc extens consequ neural connect neurit damag atrophi observ various brain injuri disord understand intrins pathway neurit outgrowth essenti develop strategi stimul neurit regener insulin pivot hormon regul glucos homeostasi increas evid neurotroph function insulin includ induct neurit outgrowth howev associ mechan remain elus demonstr insulin potenti neurit outgrowth mediat small gtpase adp ribosyl factor arf ras relat c botulinum toxin substrat rac neuron adaptor fe moreov insulin enhanc atyp protein kinas c pkc activ fe phosphoryl serin neuron mous brain vitro cellular assay show pkc phosphoryl fe consist insulin potenti fe phosphoryl presenc pkc phosphomimet studi show fe se mutant potent activ arf rac neurit outgrowth notabl phosphomimet mutat enhanc fe arf interact process promot arf rac mediat neurit outgrowth likewis insulin treatment pkc overexpress potenti fe arf interact convers pkc knockdown suppress stimulatori effect fe arf rac mediat neurit outgrowth effect insulin neurit outgrowth also mark attenu pkc knockdown neuron presenc absenc fe find reveal novel mechan link insulin arf rac depend neurit extens pkc mediat phosphoryl fe | D007328;D020830 | T125;T121;T126;T116 |
36,250,341 | first report parasit turbellarian cephalopod mollusc descript octopoxenus antarcticus gen nov sp nov platyhelminth fecampiida notenterida parasit turbellarian known various anim echinoderm crustacean annelid bivalv gastropod mollusc far howev turbellarian report cephalopod paper report parasit turbellarian giant antarct octopus megaleledon setebo dissect two specimen setebo caught ross sea antarctica found numer worm intestin liver worm spheric oblong two morpholog differ pole frontal pole bear small conic protrus contain larg elong pear shape frontal gland larg polygon cell duct frontal gland open termin form frontal organ caudal pole open shape fold tube connect genit pore common genit atrium continu canal muscular sheath worm identifi turbellarian famili notenterida fecampiida famili contain one speci notentera ivanovi report gut polychaet white sea worm found gastrointestin tract octopus morpholog similar n ivanovi differ sever import respect phylogenet analysi base rdna gene show newli found worm cluster togeth fecampiid high support clade close relat n ivanovi basi morpholog molecular data describ new speci octopoxenus antarcticus gen nov sp nov fecampiida notenterida establish new genus accommod provid updat diagnosi famili notenterida first report parasit turbellarian cephalopod mollusc | D049830;D010986 | T204 |
36,250,337 | recent advanc cell base cell free therapeut approach sarcopenia sarcopenia progress loss muscl mass function connect increas hospit expenditur fall fractur mortal although muscl loss relat age injuri hormon imbal diseas malign chronic obstruct pulmonari diseas heart failur kidney failur under pathogen mechan sarcopenia unclear exercis base intervent multimod strategi current consid potenti therapeut approach prevent treat diseas although drug therapi research ongo drug yet proven substanti safeti clinic valu first drug therapi licens sarcopenia better understand molecular alter under sarcopenia effect treatment review lead research avail find system chang muscl specif microenviron furthermor explor possibl mechan sarcopenia provid new knowledg develop novel cell free cell base therapeut review assist research develop better therapi improv muscl health elder | D006333;D055948 | T047;T046 |
36,250,332 | multicentr randomis control trial investig effect parent touch reliev acut procedur pain neonat petal newborn infant routin undergo minor pain procedur part postnat care infant born sick prematur requir greater number procedur pain earli life long term neurodevelopment consequ lead parent anxieti futur avoid intervent effect pain manag essenti non pharmacolog comfort measur breastfeed swaddl sweet solut inconsist implement alway practic effect reduc transmiss noxious input brain stroke skin activ c tactil fibr reduc pain therefor could provid simpl safe parent led intervent manag pain trial aim determin whether parent touch prior pain clinic procedur provid effect pain relief neonat | D000073818 | T184 |
36,250,331 | mitochondri mitophagi protect combin rivaroxaban aspirin high glucos expos human coronari arteri endotheli cell vitro studi combin rivaroxaban plus aspirin improv cardiovascular outcom patient stabl cardiovascular diseas aim determin rivaroxaban acetylsalicyl acid alon combin may protect mitochondri mitophagi human coronari arteri endotheli cell hcaec expos glucos | D001241;D000069552 | T121;T109 |
36,250,323 | two close relat ureotel fish speci genus alcolapia express differ level ammonium transport gill fish excret nitrogen wast across gill ammonia activ rhesus glycoprotein ammonium transport contrast fish subgenus alcolapia oreochromi vertebr surviv extrem condit soda lake natron magadi east africa evolv adapt high alkalin water includ abil excret nitrogen wast urea nevertheless alcolapia retain rhesus glycoprotein gene genom use two heterolog express system demonstr alcolapia rhbg capabl move ammonia compar ammonia urea excret two close relat alcolapia speci aquarium found alcolapia grahami remain fulli ureotel mani generat lab condit alcolapia alcalica excret nitrogen wast ammonia use situ hybridis demonstr robust localis gene express rhbg rhcg rhcg gill tissu alcalica embryo adult similar ammoniotel fish contrast express gene grahami gill much lower alcalica suggest rapid evolut molecular mechan under complet ureotel grahami | D005880;D064751 | T104;T023;T197 |
36,250,320 | cryogen ir uv spectroscopi isom select cytosin radic cation oxid nucleobas great concern stabil dna strand consid sourc mutagenesi cancer howev precis spectroscopi data particular electron excit state scarc miss report origin way produc isom select radic cation dna base exemplifi case cytosin photodissoci cold cytosin silver c ag complex ir uv dip spectroscopi c ag featur fingerprint band two keto amino cytosin tautom uv photodissoci uvpd isom select c ag complex produc cytosin radic cation c without isomer ir uv cryogen ion spectroscopi c allow unambigu structur assign two keto amino isom c uvpd spectroscopi isom select c speci record uniqu spectral resolut benchmark spectroscop data electron excit state c use assess quantum chemistri calcul perform td dft casscfcaspt casscfmrci f level | D003596;D004247 | T123;T114;T109 |
36,250,305 | novel three dimension molecular imprint polypyrrol electrochem sensor base mof deriv porous carbon nitrogen dope graphen ultrasensit determin dopamin herein novel molecular imprint polypyrrol electrochem sensor fabric base zirconia carbon core shell structur zro c nitrogen dope graphen npg modifi glassi carbon electrod gce ultrasensit recognit dopamin da npg prepar sacrifici templat assist pyrolysi method zro c synthes via anneal treatment zirconium base metal organ framework uio conveni electropolymer method use prepar pyrrol py conduct molecular imprint polym mip presenc da elut process da perform simpl overoxid process alkalin condit differenti puls voltammetri dpv use assess electrochem perform sensor mip base electrochem sensor specif bind site could use select recognit da optim condit linear rang sensor mol l detect limit mol l sn sensor exhibit suitabl select stabil reproduc suggest could promis candid rapid diagnost method dopamin investig | D006108;D054802 | T063;T196;T109 |
36,250,295 | unblock rigid purin mof kinet separ xylen separ xylen isom still remain industri challeng task porous purin base metal organ framework mof synthes studi potenti xylen separ particular zn purin show excel para xylen ortho xylen separ capabl diffus select high equilibrium adsorpt select indic coadsorpt experi high select attribut shape size channel apertur within rigid framework zn purin | D014992;D000073396 | T121;T130;T109 |
36,250,291 | copper catalyz three compon reaction dithioacet diazo keton ketimin copper catalyz three compon reaction dithioacet diazo keton ketimin report reaction proceed via trap high activ sulfur ylide speci generat thioacet carben intermedi isatin deriv ketimin provid effici protocol synthesi acycl thioacet deriv medium size sulfur contain heterocycl good high yield mild reaction condit broad substrat scope | D007659;D003300 | T123;T196;T121;T109 |
36,250,282 | autosom domin tubulointerstiti kidney diseas review clinic characterist autosom domin tubulointerstiti kidney diseas adtkd includ bland urinari sediment slowli progress chronic kidney diseas ckd mani patient reach end stage renal diseas esrd age year autosom domin inherit due advanc genet diagnosi adtkd becom increas recogn caus ckd pathogen variant umod muc ren common caus adtkd adtkd umod also associ hyperuricemia gout adtkd ren often present childhood mild hypotens ckd hyperkalemia acidosi anemia adtkd muc patient present ckd review describ pathophysiolog genet clinic manifest diagnosi adtkd emphasi genet test genet counsel suggest patient | D005820;D051436 | T060;T047;T059 |
36,250,273 | reduc graphen oxid support cuo nanoparticl synergist enhanc electrocatalyt activ nitric oxid sens import signal molecul nitric oxid involv varieti physiolog pathophysiolog process make real time detect imper physiolog environ howev probe physiolog system remain great challeng due short half life low concentr rapid diffus easi interfer chemic note tradit detect method often requir time consum sampl pretreat use continu monitor vivo herein report copper oxid decor reduc graphen oxid rgocuo synthes via facil eco friend solvotherm method take advantag synerget effect cuo rgo rgocuo sensor demonstr impress electrochem perform detect low detect limit nm wide linear rang nm high sensit cm import prepar sensor also show excel select repeat reproduc long term oper stabil fast respons detect meet requir monitor releas live cell therefor believ report rgocuo sensor great potenti vivo detect even clinic diagnosi | D006108;D053758 | T196;T073;T109 |
36,250,267 | go flow bulk transport molecular motor cell smallest build block live eukaryot organ usual rang coupl micromet exampl platelet hundr micromet exampl neuron oocyt size eukaryot cell diamet often self organ larg scale movement cytoplasm content known cytoplasm stream occur compens physic constraint larg cell review discuss cytoplasm stream multipl cell type mechan drive event particular focus molecular motor respons cytoplasm movement biolog role cytoplasm stream cell final describ bulk intercellular flow transport cytoplasm materi oocyt sister germlin cell drive rapid oocyt growth | D029721;D016547 | T123;T126;T116 |
36,250,261 | drug safeti evalu ixekizumab psoriasi review current knowledg sinc anti il avail concern safeti rais due inhibit physiolog activ il play immun respons infect ixekizumab human monoclon antibodi specif target il approv treatment moder sever psoriasi | D011565;D015212;D003879 | T121;T047 |
36,250,253 | detach bovin corneal endotheli cell sheet cool induc surfac hydrat poli r hydroxybutyr base thermorespons copolym coat cell sheet technolog cst fascin scaffoldless tissu engin techniqu generat physiolog repres tissu replac autolog sourc compar convent enzymat cell harvest method cst enabl preserv import cell cell junction extracellular matrix ecm compon howev coval graft method often employ cst studi seri triblock copolym hydrophob biocompat poli r hydroxybutyr phb central block flank vari length termin poli n isopropylacrylamid pnipaam block pnipaam phb pnipaam synthes via atom transfer radic polymer nipaam thermorespons triblock copolym explor non coval surfac coat cultur detach bovin corneal endotheli cell bcec sheet aqueous solut triblock copolym produc thermosensit micell drop cast glass substrat result temperatur respons surfac import incorpor central hydrophob phb block enabl anchor coat bare substrat enhanc prolifer rate bcec studi effect detach intact cell sheet also demonstr via cool treatment c min viabil detach cell sheet found unaffect cool work may potenti inspir studi involv non coval thermorespons polym coat corneal tissu engin applic | D008823;D011108 | T104;T122;T109 |
36,250,245 | review evid surround preserv free tafluprosttimolol fix dose combin therapi open angl glaucoma ocular hypertens manag focus efficaci safeti toler elev intraocular pressur iop import modifi risk factor irrevers sight loss open angl glaucoma oag topic fix dose combin fc preserv free pf tafluprost timolol tafluprosttimolol among second line iop lower option oag ocular hypertens oht | D009798;D005902;D005901 | T047 |
36,250,233 | rapid effici synthes tryptophan use continu flow quatern substitut reaction gramin chiral nucleophil glycin equival continu flow quatern reaction gramin mei lt min follow substitut reaction chiral nucleophil glycin deriv ni complex lt min success develop afford correspond alkyl ni complex good yield excel diastereoselect base result one pot quatern substitut reaction gramin batch process continu flow process allow safe effici scale synthesi j yield de g h give azatryptophan deriv j readili acid catalyz hydrolysi reaction follow protect fmoc group present method rapid effici synthes enantiopur unnatur tryptophan deriv various gramin use promot peptid protein drug discoveri develop research | D005998;D014364 | T123;T121;T116;T109;T046 |
36,250,155 | determin covid vaccin hesit pandem cross section survey canton vaud switzerland object covid vaccin hesit major obstacl fight pandem studi aim identifi local determin vaccin hesit context covid better inform futur immun campaign method studi conduct februari includ random select inhabit canton vaud switzerland onlin questionnair investig determin intent vaccin previous valid score cronbach alpha appli data inclus ordin logist regress model result individu like vaccin year older wealthi report high educ attain report comorbid doubt regard vaccin safeti efficaci mistrust author propens natur immun identifi main local hindranc covid vaccin conclus outreach peopl risk sever covid particular relev pandem context help mitig vaccin hesit canton vaud take consider level educ investig need better understand reason mistrust author | D000086382;D000086663 | T200;T047;T067 |
36,250,154 | hybrid multipl criteria decis make model home healthcar nurs job satisfact evalu improv object investig evalu key factor relat job satisfact perform home healthcar nurs hhns method total hhns three communiti hospit zhejiang provinc invit particip studi complet questionnair survey base home healthcar nurs job satisfact scale hhnjs februari march consist fuzzi prefer relat cfpr method import perform analysi ipa use obtain attribut weight perform hhns job satisfact result result show attribut c c c c c c c c key factor influenc hhns job satisfact conclus hybrid multipl criteria decis make mcdm model help home healthcar agenc administr better understand key factor relat hhns job satisfact establish reason improv strategi | D006699;D009726 | T058;T097 |
36,250,153 | obes metabol phenotyp chang time risk diabet mellitus observ prospect studi general popul object evalu distribut chang differ obes metabol phenotyp well impact incid type diabet mellitus tdm northwest chines popul sampl method data come prospect cohort studi n mean follow year particip classifi four group combin chines diabet societi cds diagnost criteria metabol syndrom anthropometr measur metabol healthi normal weight mhnw metabol healthi overweightobes mho metabol unhealthi normal weight munw metabol unhealthi overweightobes muo cox regress model time depend covari use evalu chang obes metabol phenotyp risk tdm result particip muo state highest risk develop tdm incid densiti person year mho muo group show increas risk incid diabet base bodi mass index bmi hr ci p hr ci p respect besid mho group increas risk incid diabet base waist circumfer wc hr ci p conclus diabet frequent mho muo group co occurr obes metabol abnorm contribut develop tdm | D003924;D024821;D000067329 | T184;T047 |
36,250,151 | effect electron cigarett lung function compar non electron cigarett systemat analysi object effect e cigarett lung function compar e cigarett non e cigarett group well self chang inhal e cigarett method march st relev literatur select four databas predefin retriev strategi strict literatur screen qualiti evalu conduct studi follow prisma guidelin result result show co smd feno smd signific decreas e cigarett usag asthmat smoker show statist signific increas flow resist inhal e cigarett convers decreas fevfvc non e cigarett group exceed e cigarett group smd degre satur decreas also less cigarett group smd especi compar convent cigarett group smd conclus current find indic short term e cigarett inhal similar signific effect lung function compar non e cigarett clinic studi need explor safeti inhal e cigarett especi vulner popul | D066300;D062789;D000072137 | T131;T073;T055;T109 |
36,250,150 | intern comparison self concept self percept lifestyl adolesc systemat review object adolesc consid vital time address healthi attitud valu toward effect transit adulthood aim review analys self concept self percept physic exercis lifestyl late adolesc popul method systemat review studi assess result rosenberg self esteem scale general health questionnair activ questionnair adolesc health behaviour school age children questionnair late adolesc prisma recommend follow casp qualiti check system appli exclud articl score result studi found articl select adolesc high self concept self percept tend emot stabl sociabl respons signific differ found regard self concept self percept differ countri differ men women physic activ healthi diet improv self concept percept bodi imag conclus self concept self percept associ respons stabil mental strength healthi behaviour adolesc follow adulthood socio cultur level health scienc student differenti factor overweight obes | D008019;D012649 | T041;T047;T054 |
36,250,149 | preval rapid weight loss olymp style wrestler methodolog appli rapid weight loss rwl among elit wrestler quit unexplor therefor aim studi analyz preval sourc influenc method use rwl determin differ wrestl style | D054368;D014952 | T121;T056 |
36,250,148 | exercis metabolom acut aerob anaerob signatur exercis modal differenti alter bodi composit physic perform metabol chang under outcom track assess circul metabolit global respons acut bout aerob anaerob exercis compar serum male femal subject use discoveri base metabolom platform | D015444;D055442 | T061;T056;T039;T070 |
36,250,147 | effect carbohydr protein supplement strategi endur capac muscl damag endur runner doubl blind control crossov trial purpos studi explor effect carbohydr carbohydr plus protein supplement endur capac muscl damag | D004040;D010807 | T079;T109 |
36,250,064 | abnorm prostat microbiota composit associ experiment autoimmun prostat complic depress rat microbiota play essenti role pathogenesi prostat depress howev chang prostat microbiota yet explor rat prostatitisdepress studi aim investig chang prostat microbiota rat prostatitisdepress | D001327;D064307;D011472 | T001;T047;T032;T028 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.